EUGIA PHARMA Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EUGIA PHARMA, and what generic alternatives to EUGIA PHARMA drugs are available?
EUGIA PHARMA has one hundred and sixty-eight approved drugs.
There is one US patent protecting EUGIA PHARMA drugs. There are three tentative approvals on EUGIA PHARMA drugs.
There are ten patent family members on EUGIA PHARMA drugs in nine countries and three hundred and thirty-five supplementary protection certificates in eighteen countries.
Summary for EUGIA PHARMA
| International Patents: | 10 |
| US Patents: | 1 |
| Tradenames: | 142 |
| Ingredients: | 134 |
| NDAs: | 168 |
| Patent Litigation for EUGIA PHARMA: | See patent lawsuits for EUGIA PHARMA |
Drugs and US Patents for EUGIA PHARMA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | CISATRACURIUM BESYLATE PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 209665-001 | Oct 27, 2020 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Eugia Pharma | DACTINOMYCIN | dactinomycin | INJECTABLE;INJECTION | 203385-001 | Nov 9, 2017 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Eugia Pharma | MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 216732-001 | Oct 30, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Eugia Pharma | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 213885-004 | Mar 6, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for EUGIA PHARMA Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2948148 | ⤷ Try a Trial |
| Japan | 2017514924 | ⤷ Try a Trial |
| China | 106456654 | ⤷ Try a Trial |
| Brazil | 112016026140 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for EUGIA PHARMA Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0473687 | SPC/GB98/030 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: FOSPHENYTOIN SODIUM (3-HYDROXYMETHYL)-5,5-DIPHENYLHYDANTOIN DISODIUM PHOSPHATE ESTER); REGISTERED: UK 0019/0157 19980204 |
| 0290047 | 97C0108 | Belgium | ⤷ Try a Trial | PRODUCT NAME: MANGAFODIPIR TRISODIUM (ANHYDROUS) CORRESP. MANGAFODIPIR; REGISTRATION NO/DATE: EU/1/97/040/001 19970522 |
| 0084999 | 2002C/012 | Belgium | ⤷ Try a Trial | PRODUCT NAME: FONDAPARINUX SODIQUE; REGISTRATION NO/DATE: EU/1/02/206/001 20020321 |
| 0817775 | 06C0010 | France | ⤷ Try a Trial | PRODUCT NAME: ERLOTINIB HYDROCHLORIDE; NAT. REGISTRATION NO/DATE: EU/1/05/311/001 20050919; FIRST REGISTRATION: LI - 57266 20050321 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
